• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规化学和血液学参数的移动平均质量控制 - 实施工具包。

Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementation.

机构信息

Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

Clin Chem Lab Med. 2022 Sep 2;60(11):1719-1728. doi: 10.1515/cclm-2022-0655. Print 2022 Oct 26.

DOI:10.1515/cclm-2022-0655
PMID:36044749
Abstract

OBJECTIVES

Moving average quality control (MA QC) is a patient-based real-time quality control system. Advantages compared to conventional periodic internal quality control (IQC) include absence of commutability problems and continuous monitoring of performance. We implemented MA QC for multiple routine hematology and chemistry parameters. We describe the evaluation process and provide practical tools to aid MA QC implementation.

METHODS

Nine parameters (serum sodium, calcium, bicarbonate and free thyroxine, hemoglobin [Hb], mean corpuscular volume, mean corpuscular hemoglobin concentration [MCHC], reticulocyte count and erythrocyte sedimentation rate [ESR]) were chosen for initial consideration. Using data extractions from the laboratory information system (LIS; General Laboratory Information Management System), evaluation of usefulness and optimization of MA QC settings was performed using bias detection curves. After this, MA QC settings were incorporated in our LIS for further evaluation and implementation in routine care.

RESULTS

Three out of nine parameters (Hb, ESR, and sodium) were excluded from MA QC implementation due to high variation and technical issues in the LIS. For the six remaining parameters, MA QC showed added value to IQC and was therefore implemented in the LIS. For three parameters a direct MA alarm work-up method was set up, including newly developed built-in features in the LIS. For the other parameters, we identified MA utilization beyond real-time monitoring.

CONCLUSIONS

Implementation of MA QC has added value for our laboratory setting. Additional utilization beyond real-time QC monitoring was identified. We find MA QC especially useful for trend monitoring, detection of small shifts after maintenance and inter-analyzer comparisons.

摘要

目的

移动平均质量控制(MA QC)是一种基于患者的实时质量控制系统。与传统的定期内部质量控制(IQC)相比,它具有无可比性问题和连续监测性能的优势。我们为多个常规血液学和化学参数实施了 MA QC。我们描述了评估过程,并提供了实用的工具来帮助实施 MA QC。

方法

选择了九个参数(血清钠、钙、碳酸氢盐和游离甲状腺素、血红蛋白[Hb]、平均红细胞体积、平均红细胞血红蛋白浓度[MCHC]、网织红细胞计数和红细胞沉降率[ESR])进行初步考虑。使用实验室信息系统(LIS;通用实验室信息管理系统)中的数据提取,使用偏差检测曲线对有用性进行评估和 MA QC 设置的优化。在此之后,将 MA QC 设置合并到我们的 LIS 中,以便在常规护理中进一步评估和实施。

结果

由于 LIS 中的高变异性和技术问题,九个参数中的三个(Hb、ESR 和钠)被排除在 MA QC 实施之外。对于其余的六个参数,MA QC 对 IQC 具有附加价值,因此在 LIS 中实施。对于三个参数,建立了直接的 MA 报警工作流程,包括 LIS 中内置的新开发功能。对于其他参数,我们确定了 MA 的利用超出了实时监测。

结论

在我们的实验室设置中,实施 MA QC 具有附加价值。除了实时 QC 监测之外,还确定了其他利用 MA QC 的方法。我们发现 MA QC 特别适用于趋势监测、维护后小偏移的检测以及不同分析仪之间的比较。

相似文献

1
Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementation.常规化学和血液学参数的移动平均质量控制 - 实施工具包。
Clin Chem Lab Med. 2022 Sep 2;60(11):1719-1728. doi: 10.1515/cclm-2022-0655. Print 2022 Oct 26.
2
Ten-Month Evaluation of the Routine Application of Patient Moving Average for Real-Time Quality Control in a Hospital Setting.在医院环境中常规应用患者移动平均值进行实时质量控制的十个月评估。
J Appl Lab Med. 2020 Nov 1;5(6):1184-1193. doi: 10.1093/jalm/jfaa071.
3
Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds.设计和实施整合移动平均值和内部质量控制的质量控制计划:融合两者的最佳实践。
Clin Chem Lab Med. 2019 Aug 27;57(9):1329-1338. doi: 10.1515/cclm-2019-0027.
4
Implementation and application of moving average as continuous analytical quality control instrument demonstrated for 24 routine chemistry assays.移动平均法作为连续分析质量控制工具的实施与应用在24项常规化学检测中得到了验证。
Clin Chem Lab Med. 2017 Jul 26;55(8):1142-1151. doi: 10.1515/cclm-2016-0696.
5
Moving average procedures as an additional tool for real-time analytical quality control: challenges and opportunities of implementation in small-volume medical laboratories.移动平均法作为实时分析质量控制的附加工具:在小体积医学实验室中的实施挑战和机遇。
Biochem Med (Zagreb). 2022 Feb 15;32(1):010705. doi: 10.11613/BM.2022.010705. Epub 2021 Dec 15.
6
Moving average quality control: principles, practical application and future perspectives.移动平均质量控制:原理、实际应用和未来展望。
Clin Chem Lab Med. 2019 May 27;57(6):773-782. doi: 10.1515/cclm-2018-0795.
7
Technical quality assurance and quality control for medical laboratories: a review and proposal of a new concept to obtain integrated and validated QA/QC plans.医学实验室的技术质量保证和质量控制:审查并提出一个新概念,以获得综合和经过验证的 QA/QC 计划。
Crit Rev Clin Lab Sci. 2022 Dec;59(8):586-600. doi: 10.1080/10408363.2022.2088685. Epub 2022 Jun 25.
8
Integrating moving average control procedures into the risk-based quality control plan in small-volume medical laboratories.将移动平均控制程序整合到小体积医学实验室基于风险的质量控制计划中。
Biochem Med (Zagreb). 2022 Jun 15;32(2):020711. doi: 10.11613/BM.2022.020711.
9
Benefits, limitations, and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice.基于患者的实时质量控制(PBRTQC)的益处、局限性和争议以及该实践背后的证据。
Clin Chem Lab Med. 2021 Mar 10. doi: 10.1515/cclm-2021-0072.
10
Application of Patient-Based Real-Time Quality Control Based on Artificial Intelligence Monitoring Platform in Continuously Quality Risk Monitoring of Down Syndrome Serum Screening.基于人工智能监测平台的患者实时质量控制在唐氏综合征血清筛查持续质量风险监测中的应用。
J Clin Lab Anal. 2024 Mar;38(5):e25019. doi: 10.1002/jcla.25019. Epub 2024 Mar 11.

引用本文的文献

1
Rules for mass spectrometry applications in the clinical laboratory.临床实验室质谱应用的规则。
Anal Bioanal Chem. 2023 Sep;415(21):5049-5055. doi: 10.1007/s00216-023-04648-0. Epub 2023 Mar 25.